Imclone Systems Inc. (NDAQ:IMCL) revealed today in a
13D/A filing with the SEC today that Carl Icahn has filed his preliminary consent solicitation statement to remove Kies and others from the Board of Directors and replace them with his own nominations. This news comes after the 13.85% holder of the company announced that it would seek to remove Kies (
past article).
Related CompaniesMedarex, Inc. (MEDX)Amgen, Inc. (AMGN)OSI Pharmaceuticals, Inc. (OSIP)